Inflation May Be Cooling Off This Winter. Is This Good News for the Supply Chain?

In a win for consumers and businesses alike, a key finding from the latest Bureau of Labor Statistics report suggests that inflation may be cooling off at a faster rate than expected. Comparing wholesale prices to a year ago, an 8% increase is the smallest annual increase since July of last year.

With PPI numbers giving some optimism to bulk buyers, what does this potential inflation cool-down mean for the supply chain? Will this ease any of the B2B pain felt between suppliers and buyers as both parties try to fend off the rising cost of raw materials, fuel, and logistics in general? Chief Strategy Officer at Cargomatic, Weston Labar, weighs in on the supply chain’s outlook.

Weston’s Thoughts

“The recent news about the producer pricing index comes as very welcoming for many of the nation’s economists. It shows that there’s a softening in the increased rise of inflation, and couple that with a very strong job market and consumer spending habits through the holiday season. The National Retail Federation is showing record setting consumer spending this holiday season, coupled with steady credit card rates between 18% and 22%. What we’re seeing is the American consumer continues to buy, which is good news for the economy.

Much of the transportation-related inflation, based on congestion from overseas ports and manufacturing centers to the distribution network throughout the United States, has cooled off significantly this quarter, with trucking capacity becoming more available and the ability to move goods to and from warehouses and distribution centers, and get them into stores and homes has become much more affordable for many of our nation’s retailers.

The nation’s retailers also by-and-large front-loaded their products earlier this year not to have missed seasonal goods as they saw in 2021, meaning that they pivoted from a just-in-time to a just-in-case distribution network, which has helped them by having goods here, controlling the cost of goods by-and-large the second half of 2022, and moving into 2023 in a much more advantageous position as it relates to procuring transportation needs, whether that be shipping, rail or trucking.”

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More